Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanwu capsules are a traditional Chinese medicine (TCM) formula manufactured by Yunnan Jinwu Pharmaceutical Co., Ltd. The product is a coated pill, brown to tan in color, with a slight odor, a slightly sweet taste, and a bitter aftertaste. It is composed of multiple herbal ingredients including raw aconite, raw Sichuan aconite, Polygonum multiflorum, aconite root (aconite slices), raw white aconite root, frankincense, rock sugar, and fresh pig's trotters. Sanwu capsules are indicated for conditions such as Arthralgia syndrome, paralysis, traumatic arthritis, bone hyperplasia, rheumatic arthritis, and frozen shoulder. Due to its complex herbal composition, its mechanism of action is understood within the framework of TCM, likely involving anti-inflammatory and analgesic effects. Precautions include avoiding use in patients with cold and fever, pregnant women, and children.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanwu capsules.